Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-055415
Filing Date
2021-10-29
Accepted
2021-10-29 16:00:55
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea149471-s3_abvcbio.htm S-3 344093
2 FORM OF INDENTURE WITH RESPECT TO SENIOR DEBT SECURITIES, TO BE ENTERED INTO BET ea149471ex4-6_abvcbio.htm EX-4.6 368651
3 FORM OF INDENTURE WITH RESPECT TO SUBORDINATED DEBT SECURITIES, TO BE ENTERED IN ea149471ex4-7_abvcbio.htm EX-4.7 285974
4 OPINION OF HUNTER TAUBMAN FISCHER & LI LLC* ea149471ex5-1_abvcbio.htm EX-5.1 31341
5 CONSENT OF KCCW ACCOUNTANCY CORP. ea149471ex23-1_abvcbio.htm EX-23.1 3231
6 GRAPHIC image_001.jpg GRAPHIC 6874
7 GRAPHIC image_002.jpg GRAPHIC 6874
8 GRAPHIC image_003.jpg GRAPHIC 6874
9 GRAPHIC image_004.jpg GRAPHIC 6874
10 GRAPHIC image_005.jpg GRAPHIC 5861
  Complete submission text file 0001213900-21-055415.txt   1081183
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260588 | Film No.: 211363205
SIC: 2834 Pharmaceutical Preparations